山外山 (688410)
SWS Hemodialysis Care Co., Ltd.
K-Line Chart
No K-line data available
Company NameChongqing Shanwaishan Blood Purification Technology Co., Ltd.
Listing Date2022-12-26
Issue Price32.3RMB
Registered Capital31960.062210k RMB
Legal RepresentativeGao Guangyong
Registered AddressNo. 1 Ciji Road, Liangjiang New Area, Chongqing
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of blood purification equipment and consumables, and provision of chain hemodialysis medical services
Company ProfileChongqing Shanwaishan Blood Purification Technology Co., Ltd. was founded in 2001. It is a national high-tech enterprise specializing in the research, development, and production of blood purification equipment and hemodialysis consumables, as well as the construction and operation of chain dialysis centers. The company is a drafting unit for national standards and industry standards in the field of blood purification in China and is an enterprise with a complete industrial chain in blood purification.
The company's main products include a series of blood purification equipment such as hemodialysis machines, hemodiafiltration machines, continuous blood purification equipment, and hemoperfusion machines. These are clinically used to treat various critical conditions including acute and chronic renal failure, uremia, multiple organ failure, and poisoning. Currently, the SWS series of equipment has been included in the national "Selection of Excellent Domestic Medical Equipment Products" catalog.
Stock Details
1. Key Indicators
- Total Shares(W): 32131.56
- Circulating A-Shares(W): 23455.36
- Earnings Per Share(RMB): 0.3252
- Net Assets Per Share(RMB): 5.5166
- Operating Revenue(W RMB): 58428.67
- Total Profit(W RMB): 11600.42
- **Net Profit Attributable to Parent(W RMB) **: 10448.74
- Net Profit Growth Rate(%): 68.68
- Weighted Return on Equity(%): 6.0400
- Operating Cash Flow Per Share(RMB): 0.5170
- Undistributed Profit Per Share(RMB): 0.8119
- Capital Reserve Per Share(RMB): 3.6994
2. Main Business
The main business covers:
- Research, development, production, and sales of blood purification equipment and consumables
- Provision of chain hemodialysis medical services
3. Company Basic Information
- Company Name: Chongqing Shanwaishan Blood Purification Technology Co., Ltd.
- Listing Date: 2022-12-26
- Industry: Special Purpose Equipment Manufacturing
- Address: No. 1 Ciji Road, Liangjiang New Area, Chongqing
- Website: https://www.swskj.com/
- Company Profile: The company was established through the overall change of Shanwaishan Co., Ltd. into a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hunan Xiangjiang Liyuan Investment Management Co., Ltd. - Hunan Xiangjiang Da Jiankang Venture Capital Partnership (Limited Partnership) | Corporate Entity | 2817.63 | 12.01 |
| 2 | Zhuhai Xiuheng Equity Investment Partnership (Limited Partnership) | Corporate Entity | 1319.48 | 5.63 |
| 3 | Penghua Pharmaceutical Technology Equity Securities Investment Fund Class A | Fund | 518.20 | 2.21 |
| 4 | China Ping An Insurance (Group) Co., Ltd. Enterprise Annuity Plan - China Merchants Bank Co., Ltd. | Annuity | 378.18 | 1.61 |
| 5 | Bosera Healthcare Industry Mixed Securities Investment Fund Class A | Fund | 325.70 | 1.39 |
| 6 | Ping An Stock Selection No. 3 Stock-type Pension Product - China Merchants Bank Co., Ltd. | Insurance | 325.42 | 1.39 |
| 7 | Haichuang (Shanghai) Private Fund Management Co., Ltd. - Haichuang Value Growth Selection No. 1 Private Securities Investment Fund | Private Securities Investment Fund | 250.00 | 1.07 |
| 8 | Guoshou Anbao Health Science Mixed Securities Investment Fund Class A | Fund | 20.00 | 0.09 |
| 9 | GF Asset Management Shengsheng Selected Mixed Collective Asset Management Plan | Fund | 15.00 | 0.06 |
| 10 | Dongxing Pharmaceutical Biotechnology Quantitative Stock Selection Mixed Securities Investment Fund Class A | Fund | 0.87 | 0.00 |
5. Concept Sectors
- Private Hospitals
- Smart Healthcare
- Margin Trading & Securities Lending
- Share Buyback Plan
- Proposed Reduction
- Insurance New Holdings
- Specialized, Refined, Distinctive, and Innovative (SRDI)
- Private Placement New Holdings
- STAR 200
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information